Alnylam Pharmaceuticals Inc (ALNY)

[urche]

Not even mentioned in the PR by ALNY is Tekmira's role in producing ALN-PCS. This is not surprising since the two companies are embroiled in lawsuits, but TKMR was quick to produce its own spin on the ALNY news.

Tekmira's LNP Technology Enables Alnylam's Positive ALN-PCS Clinical Data4-20-12 10:51 AM EDT

VANCOUVER, British Columbia, April 20, 2012 (GLOBE NEWSWIRE) -- Tekmira Pharmaceuticals Corporation (Nasdaq:TKMR) (TSX:TKM), a leading developer of RNA interference (RNAi) therapeutics, today reported that Alnylam Pharmaceuticals, Inc. presented positive clinical results from its Phase 1 clinical trial of ALN-PCS, an RNAi therapeutic targeting PCSK9 for the treatment of severe hypercholesterolemia, which utilizes Tekmira's lipid nanoparticle (LNP) technology and is manufactured by Tekmira.......